Pharmaceutical Technology

JUNE 20, 2024

Researchers at the University of Birmingham have discovered a mechanism of enzyme communication that could aid drug development.

Drug Development 52

Drug Development Communication 52

Pharmaceutical Technology

DECEMBER 7, 2022

Visit our privacy policy for more information about our services, how we may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Please check your email to download the Report.

Drug Development 105

Drug Development Communication Immunity Immunization 105

pharmaphorum

OCTOBER 1, 2021

The COVID-19 pandemic kickstarted a period of profound change in how the pharmaceutical industry approaches both communications and commercialisation. The pharma company’s senior vice president for major markets talks about the continued evolution of the industry’s approach to communications and commercialisation.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Drug Development 52

Pharmaceutical Technology

FEBRUARY 23, 2023

As formulators, we are often able to directly impact the amount of drug absorbed through formulation optimization and improve exposure. However, the chances of improving the exposure profile of a drug that is highly cleared by formulation modification are limited. Please check your email to download the Whitepaper. S54 – S61 (2001).

Drug Development 98

Drug Development Compounding Dosage Packaging 98

Pharma Marketing Network

OCTOBER 28, 2023

It is a shift from a traditional focus on drug development and marketing to a focus on the patient’s needs. This shift is being driven by advances in digital communication, which are allowing companies to better understand and meet the needs of their patients.

Communication 52

Communication Drug Development 52

Pharmaceutical Technology

DECEMBER 7, 2022

Visit our privacy policy for more information about our services, how we may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Please check your email to download the Report.

Drug Development 98

Drug Development Communication Immunity Immunization 98

FDA Law Blog: Biosimilars

APRIL 1, 2025

A less robust schedule of external meetings and slower pace of publications of Guidance to Industry may further slow communication to sponsors who eagerly await information critical to inform their development programs. Just as important will be the need to respond expertly, efficiently and meaningfully to FDA concerns.

Communication 77

Communication Drug Development 77

Drug Patent Watch

DECEMBER 10, 2024

Generic drug development is a complex process that requires a deep understanding of regulatory requirements and guidelines. Regulatory expertise plays a crucial role in ensuring that generic drugs meet the necessary standards for quality, safety, and efficacy. EU, and other regions. ” Scientific Research Publishing , 2024.

Drug Development 52

Drug Development Communication 52

pharmaphorum

JULY 1, 2021

These CDISC standards must be successfully implemented at different stages in the drug development process. How do CDISC standards fit into the drug development process? That means your team has greater control, transparency and communication. The post How do CDISC standards fit into the drug development process?

Drug Development 72

Drug Development Communication 72

Pharmaceutical Business Review

MAY 20, 2025

The fast track designation aims to accelerate the new drug development and review that fills an unmet medical need or treats life-threatening conditions.

Communication 52

Communication Drug Development 52

Pharma Marketing Network

NOVEMBER 23, 2024

Research gathered from real-world settings offers invaluable insights into drug efficacy, safety, and patient preferences. Trends in Drug Development and Launch Strategies Drug development trends, such as accelerated approvals and adaptive trials, require marketers to stay agile.

Drug Development 52

Drug Development Communication 52

Pharmafile

MARCH 31, 2023

Japan-based NEC Corporation has announced that it is realigning its subsidiaries in order to streamline its AI drug development services. All will continue to work with partners in order to move forward with preclinical and clinical development in the infectious diseases and oncology fields. read more

Drug Development 52

Drug Development Communication 52

pharmaphorum

JANUARY 25, 2021

The pandemic has propelled the life science industry toward higher expectations for faster, more responsive and more inclusive drug development. It is likely we will begin to see the public ask more questions, which in turn may require more regular and ongoing communication efforts by industry stakeholders.

Communication 124

Communication Drug Development 124

Pharmaceutical Technology

JUNE 15, 2023

Drug development is already a difficult endeavor, with the vast majority of R&D efforts failing to produce a market-worthy product. Even reaching the clinical trial phase offers no guarantees, as only 12% of such drugs receive U.S. While this process is essential, it’s also slow, expensive and unpredictable.

Drug Development 52

Drug Development Compounding Adverse Reactions Dosage 52

pharmaphorum

OCTOBER 11, 2022

Asked how he made the shift from working out the structure of proteins and how molecules bind to those proteins, to the founding of pharmaphorum and focusing on the digital space, his answer was clear: communication. Tunnah realised, in fact, that that communicative passion lay within himself and wasn’t satisfied by academic work.

Communication 98

Communication Diabetes Drug Development 98

Pharmaceutical Technology

APRIL 6, 2023

The US Food and Drug Administration (FDA) has released the fourth and final chapter in a series of guidance documents designed to support patient-focused drug development. The draft guidance, released on March 5, is open for comments until May 7, after which it will replace an earlier 2009 guidance for the industry.

Drug Development 52

Drug Development Documentation Communication 52

European Pharmaceutical Review

SEPTEMBER 22, 2022

Identifying and actioning solutions to fast-track drug development for the diseases is a vital aim of the project. Due to the progressive, and eventually fatal nature of the diseases, finding a cure quickly is of upmost importance to the pharmaceutical community.

Drug Development 98

Drug Development Communication 98

Pharmaceutical Technology

DECEMBER 6, 2022

HPAPIs may now represent more than 30% of the drug development pipeline. Within that figure, GlobalData estimates that around 60% of pipeline HPAPIs are developed to target oncology. In the early stages of drug development, protecting operators from unknown risks is absolutely crucial.

Drug Development 52

Drug Development Dosage Pharmaceutical Manufacturing Communication 52

Pharmacy Is Right For Me

APRIL 4, 2023

There are so many different types of careers within the field of pharmacy—from research and drug development to pharmacy informatics! It also improves care coordination and eliminates communication gaps. It involves the training of community paramedics in performing some aspects of medication reconciliation.

Hospitals 130

Hospitals Communication Medical Records Dosage 130

pharmaphorum

NOVEMBER 2, 2022

With the merger now completed, Norstella becomes a $5 billion group with 1,500 employees across the five business brands with the overarching objective of guiding life sciences companies through the drug development process so patients can get access to therapies more quickly.

Drug Development 101

Drug Development Communication 101

pharmaphorum

AUGUST 26, 2021

There are many benefits of including patients at every stage of the drug development process, as well as ways to involve them in the early stages of drug development. It helps to focus the drug development process on its main element – the patient, and it also makes good business sense, too.

Drug Development 105

Drug Development Communication 105

Pharmaceutical Technology

FEBRUARY 16, 2023

It may offer opportunities for third-party collaborations to guide the new cell therapies and drugs development, if successful. It enables quick evaluation of a patient tumour response to a range of cancer drug modalities within 14 days of obtaining harvested samples of tumour cells.

Drug Development 96

Drug Development Communication 96

pharmaphorum

APRIL 19, 2021

Prime Global, the international medical communications and market access group, has appointed Emma Sutcliffe as senior vice president, patient insights and solutions. Sutcliffe will lead on patient engagement and support Prime Global’s seven agencies and four consultancies to deliver patient-centric communications.

Communication 59

Communication Drug Development 59

pharmaphorum

JUNE 30, 2022

At the 2022 Drug Information Association (DIA) annual meeting last week, it was inspiring to connect with fellow research and development (R&D) stakeholders, regulators, health and digital data partners and more to navigate challenges in drug development that impact patients globally. Patient journey. Delivery models.

Drug Development 64

Drug Development Communication 64

Express Pharma

SEPTEMBER 4, 2023

Enzene Biosciences inaugurated research and development (R&D) facility in Pune. Enzene’s new R&D facility, spanning over 75,000 sq ft, is equipped with an open lab set-up to promote cross-departmental collaboration, efficient communication, and knowledge sharing.

Communication 110

Communication Drug Development 110

pharmaphorum

DECEMBER 15, 2021

It is drug developers, patients, advocates, and caregivers in active conversations—more likely to involve clean sheets of paper than prepared scripts. The goal must be to reference what has been learned at every stage of the drug-development pipeline—so that patient insights become guiding principles rather than afterthoughts.

Drug Development 145

Drug Development Communication Hospitals 145

European Pharmaceutical Review

SEPTEMBER 14, 2023

There was a significant slowdown in drug development, clinical trials, and new drugs coming to market. EMA prepares for winter antibiotic shortages That slowdown resulted in 211 drug shortages in 2010—the highest number recorded in a single year at the time. 1 We can only learn from the past and try not to repeat history.

Drug Development 98

Drug Development Drug Pricing Communication 98

Express Pharma

AUGUST 9, 2024

2] Clear roles and responsibilities and precise communication will help bridge the gap between R&D, manufacturing and supply chain, and aid the process of tech transfer, making it effective and faster. [3] 3] Peptides drug development has seen significant progress. Hence, automating is the need of the hour. [4]

Drug Development 52

Drug Development Communication 52

pharmaphorum

NOVEMBER 1, 2021

Patient centricity isn’t a box ticking exercise – it’s a mindset that has to run the entire length of the drug development pathway. One example of patient centricity in action at Boehringer Ingelheim is how the company has changed its clinical trial communications policies, she said.

Communication 89

Communication Drug Development 89

Viseven

AUGUST 15, 2024

The traditional model of drug development and healthcare delivery is undergoing a seismic shift, with patient engagement emerging as a critical factor in achieving better health outcomes and driving innovation. This change is further driven by major regulatory bodies emphasizing Patient-Focused Drug Development (PFDD).

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Drug Development 52

European Pharmaceutical Review

FEBRUARY 22, 2023

The paper mentioned that a “chief concern for drug developers is balancing the risk of negatively impacting product quality during TS against the perceived risks of aseptic processing, that is, release of a nonsterile unit.” The authors listed some of the many technical considerations that “add to the complexity.” DeCollibus et al.

Communication 104

Communication Drug Development 104

pharmaphorum

SEPTEMBER 20, 2021

For the pharma industry, the pandemic’s changes were both abrupt and industry-altering, requiring companies to rapidly adapt their approaches to drug development and commercialisation. While many HCPs are open to receive digital communications and sampling programmes, one group that is not ready is older HCPs.

Communication 98

Communication Drug Development 98

Express Pharma

MAY 24, 2023

The day concluded with the delegates solving an exciting case study by Tahseen Rana on the drug development process while dealing with the pandemic and timelines! The second day of the conference was theme-based, i.e. Retro or Bollywood. The delegates dressed up in the styles of the 70s, 80s and 90s.

Biosimilars 96

Biosimilars Communication Drug Development 96

Express Pharma

OCTOBER 9, 2023

A study published in the journal Nature Communications has identified a new pathway that human immunodeficiency virus (HIV) uses to enter the nucleus of a healthy cell, where it can then replicate and go on to invade other cells.

Packaging 111

Packaging Communication Drug Development 111

pharmaphorum

AUGUST 24, 2020

In the United States, the 21st Century Cures Act encouraged the Food and Drug Administration (FDA) to review and communicate patient experience data from trials – but the lack of a common framework for submissions and space on product labels has, until now, been something of a stumbling block. .

Labelling 128

Labelling Communication Drug Development 128

Pharmaceutical Technology

AUGUST 29, 2022

Shanghai KangaBio founder and CEO Dr Weidong Jiang said: “KangaBio is committed to developing low toxicity and high efficacy immuno-agonists and innovative prodrugs of multi-specific antibodies.

Drug Development 52

Drug Development Communication 52

pharmaphorum

FEBRUARY 17, 2021

According to one study by The Economist Intelligence Unit Committee, therapies with a patient-centric trial design were 41% more likely to be added to the payer formulary because drugs that used this approach were 90% more likely to be launched than those that were not.

Drug Development 98

Drug Development Communication 98